A 30-year analysis of urolithiasis burden in the North Africa and Middle East region: Findings from the global burden of disease study 2021
PLOS One · 2026
DOI: 10.1371/journal.pone.0343341 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Sina Golestani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran,…. Hauptthemen laut MEDLINE: Urolithiasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Urolithiasis, a prevalent urological disorder, is associated with significant morbidity and economic burden. Despite the Global Burden of Disease (GBD) data, regional specificity for urolithiasis burden in North Africa and Middle East (NAME) remains limited. This study aims to fill this gap by analyzing the burden of urolithiasis in the NAME region from 1990 to 2021.
Methods
Data from the GBD 2021 study were used to evaluate key health measures, including incidence, prevalence, mortality, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs). Age-standardized rates (ASRs) and absolute numbers were assessed across 21 NAME countries, stratified by sex, age, and sociodemographic index (SDI). Results were presented with 95% uncertainty intervals.
Results
In 2021, the overall incidence reached 5.3 million (95% uncertainty intervals: 4.2–6.8) cases, compared to 2.0 million (1.6–2.5) in 1990. Prevalence rose from about 76,000 (61,000–96,000) cases in 1990–201,000 (160,000–257,000) in 2021. The number of deaths increased considerably from 142.1 (79.8–194.5) to 394.2 (182.4–509.5), and the DALYs rose from 10,814.0 (7,970.0–13,932.3) to 25,213.3 (17,943.5–33,787.7) from 1990 to 2021. ASRs for all burden measures remained stable and females consistently exhibited lower rates compared to males. There was a positive correlation between SDI and rates of incidence, prevalence, and YLDs; however, deaths, YLLs, and DALYs exhibited no significant correlation with SDI.
Conclusion
Urolithiasis imposes a growing health and economic burden in the NAME region, particularly among middle-aged populations and high-SDI countries. Targeted interventions and region-specific policies are crucial to address the rising disease burden effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Sina Hosspital, Tehran University of Medical Sciences, Tehran, Iran.
- Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Ozra Tabatabaei-Malazy, Bagher Larijani, Seyed Mohammad Kazem Aghamir
Zitieren
APA
Golestani, S., Talebian, M. T., Golestani, A., Ahadi, Z., Tabatabaei-Malazy, O., Fard, Z. A., Mohammadi, A., Larijani, B., & Aghamir, S. M. K. (2026). A 30-year analysis of urolithiasis burden in the North Africa and Middle East region: Findings from the global burden of disease study 2021. PLOS One. https://doi.org/10.1371/journal.pone.0343341
Vancouver
Golestani S, Talebian MT, Golestani A, Ahadi Z, Tabatabaei-Malazy O, Fard ZA, et al. A 30-year analysis of urolithiasis burden in the North Africa and Middle East region: Findings from the global burden of disease study 2021. PLOS One. 2026. doi:10.1371/journal.pone.0343341
BibTeX
@article{Golestani2026,
author = {Golestani, Sina and Talebian, Mohammad Taghi and Golestani, Ali and Ahadi, Zeinab and Tabatabaei-Malazy, Ozra and Fard, Ziba Aghsaei and Mohammadi, Abdolreza and Larijani, Bagher and Aghamir, Seyed Mohammad Kazem},
title = {A 30-year analysis of urolithiasis burden in the North Africa and Middle East region: Findings from the global burden of disease study 2021},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0343341}
}
EUVIMED